Therapy News and Research

RSS

New nanodevice lays foundations for future development of novel therapies against aging

A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.

4 Oct 2012

Estrogen/progesterone treatment started soon after menopause appears safe and effective

Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented at the North American Menopause Society (NAMS) Annual Meeting in Orlando, Florida.

4 Oct 2012

Lecture to discuss insights into genes and neurodegenerative diseases gleaned from baker's yeast

Insights into our genes and neurodegenerative diseases gleaned from humble baker's yeast, among other things, will be showcased by genetics experts at a free public lecture.

4 Oct 2012

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

XBiotech, a privately held biotechnology company, announced today that the company has been granted Fast Track designation for its anti-cachexia drug Xilonix.

4 Oct 2012

Bunker Hill Community College receives HRSA grant to support education of nursing students

The Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services has awarded Bunker Hill Community College (BHCC) a four-year, $1,050,000 grant to support the education of nursing students.

4 Oct 2012

SpineSmith receives U.S. patent for VisuALIF lumbar interbody device

SpineSmith, a Celling Biosciences company, announces that the United States Patent and Trademark Office has issued US Patent 8,273,127, covering the VisuALIF, the first lumbar interbody device featuring a revolutionary open-face design.

4 Oct 2012

Starting HIV-infected patients on ART reduces food insecurity, improves physical health

Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.

4 Oct 2012

Vitamin D3 intake does not reduce incidence or severity of upper respiratory tract infections

Although some data have suggested a possible inverse association between serum vitamin D levels and the incidence of upper respiratory tract infections (colds), participants in a randomized controlled trial who received a monthly dose of 100,000 IUs of vitamin D3 did not have a significantly reduced incidence or severity of colds, according to a study in the October 3 issue of JAMA.

4 Oct 2012

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.

3 Oct 2012

Rare study highlights anal cancer prognosis risks

The presence of palpable, clinically involved inguinal lymph nodes and male gender are both independent risk factors for poor prognosis in anal cancer, confirm the results of a UK analysis.

3 Oct 2012

Antifungal resistance of Candida genital isolates on the increase

Resistance to antifungal therapy of genital-infection causing Candida species may be an increasing problem, suggests research presented at the European Academy of Dermatology and Venereology annual congress in Prague, Czech Republic.

3 Oct 2012

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Bone marrow transplant (also called stem cell transplant) is a medical intervention that allows a physician to deliver very high doses of chemotherapy (if needed) but more importantly, deliver a new immune system to the patient to fight a disease (such as cancer).

3 Oct 2012

More access to video-EEG may reduce treatment gap for epilepsy and PNES

LpxC-1 can effectively treat antibiotic-resistant infections

A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead of killing the bacteria that cause it. Researchers report their findings in the October 2 issue of mBio-, the online open-access journal of the American Society for Microbiology.

3 Oct 2012

Beta-blockers do not appear to reduce risk of cardiovascular events in patients with CAD

Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular events that included cardiovascular death, nonfatal heart attack or nonfatal stroke, according to a study in the October 3 issue of JAMA.

3 Oct 2012

New insights on mechanisms involved in regeneration of insulin-producing cells

Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model of insulin-dependent diabetes.

3 Oct 2012

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

When Linda Tuttle was diagnosed with breast cancer, she never imagined her experience would inspire her colleagues to design new treatments to tackle the disease.

3 Oct 2012

New testing method for gestational diabetes

The increasingly common condition of gestational diabetes can have serious consequences for both the mother and child if left untreated. Prompt diagnosis and therapy can protect against these consequences. A new testing method developed at the MedUni Vienna now makes diagnosis easier and also cheaper.

3 Oct 2012

Ranibizumab injections keep those with AMD driving longer

The advanced neovascular, or “wet,” form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But results of a new study, published in the online version of the journal Ophthalmology, suggest that monthly injections of ranibizumab improve eye chart test results required for a driver’s license, build driver confidence and keep those with AMD driving longer.

3 Oct 2012

Positive results from Noven’s LDMP Phase 3 clinical studies on menopausal VMS

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced positive results from two multicenter, double-blind, randomized, placebo-controlled Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP; 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

3 Oct 2012

Therapy News and Research

New nanodevice lays foundations for future development of novel therapies against aging

Estrogen/progesterone treatment started soon after menopause appears safe and effective

Lecture to discuss insights into genes and neurodegenerative diseases gleaned from baker's yeast

FDA grants Fast Track designation to XBiotech’s Xilonix for treatment of cachexia

Bunker Hill Community College receives HRSA grant to support education of nursing students

SpineSmith receives U.S. patent for VisuALIF lumbar interbody device

Starting HIV-infected patients on ART reduces food insecurity, improves physical health

Vitamin D3 intake does not reduce incidence or severity of upper respiratory tract infections

Beta blockers do not lower cardiac risk in patients with or without CAD

Rare study highlights anal cancer prognosis risks

Antifungal resistance of Candida genital isolates on the increase

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

More access to video-EEG may reduce treatment gap for epilepsy and PNES

LpxC-1 can effectively treat antibiotic-resistant infections

Beta-blockers do not appear to reduce risk of cardiovascular events in patients with CAD

New insights on mechanisms involved in regeneration of insulin-producing cells

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

New testing method for gestational diabetes

Ranibizumab injections keep those with AMD driving longer

Positive results from Noven’s LDMP Phase 3 clinical studies on menopausal VMS

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News